Procter & Gamble Hygiene and Health Care Limited (NSE:PGHH)
India
· Delayed Price · Currency is INR | Market Cap | 445.13B |
| Revenue (ttm) | 43.17B |
| Net Income (ttm) | 7.16B |
| Shares Out | n/a |
| EPS (ttm) | 220.55 |
| PE Ratio | 62.18 |
| Forward PE | n/a |
| Dividend | 205.00 (1.47%) |
| Ex-Dividend Date | Feb 20, 2025 |
| Volume | 3,530 |
| Average Volume | 7,980 |
| Open | 13,910 |
| Previous Close | 13,987 |
| Day's Range | 13,655 - 13,973 |
| 52-Week Range | 13,655 - 17,745 |
| Beta | 0.21 |
| RSI | 34.09 |
| Earnings Date | Feb 11, 2025 |
About NSE:PGHH
Procter & Gamble Hygiene and Health Care Limited engages in the manufacture and sale of branded packaged fast-moving consumer goods in the feminine care and healthcare businesses in India and internationally. It operates through Healthcare Products and Hygiene Products segments. The company provides health care products, including ointments and creams, cough drops, and tablets; and hygiene products, such as feminine hygiene and other skin care hygiene products, as well as feminine care pads. It also offers baby care products comprising nappies,... [Read more]
Financial Performance
In 2024, NSE:PGHH's revenue was 42.06 billion, an increase of 7.35% compared to the previous year's 39.18 billion. Earnings were 6.75 billion, a decrease of -0.46%.
Financial StatementsNews
Procter & Gamble Q3 FY25 Results: Revenue up 9.68% YoY to Rs 1247.63 crore, Net profit rises 17.33% YoY
Procter & Gamble Hygiene and Health Care Limited reported a strong financial performance for the quarter ended December 31, 2024 (Q3 FY25). The company achieved notable growth in both revenue and net ...
P&G Q2 Results: Revenue at Rs 1,132.73 crore, down 0.2% YoY; Net profit at Rs 211.9 crore, up 0.6% YoY
Procter & Gamble Hygiene and Health Care Limited has released its Q2 FY25 financial results, with a slight year-over-year decline in revenue and a stable growth in net profit. The company reported rev...